Massachusetts General Hospital / Dana-Farber Cancer Institute

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells	neoplasm	Recruiting	Phase 2 / Phase 3	2026-09-18		NCT03435796

Clinical trials